Abstracts tagged "CNS Vasculitis"

Abstract Number: 1717 • 2019 ACR/ARP Annual Meeting
Identifying Patterns of Histopathologic Presentation in CNS Vasculitis
Chan Mi Lee¹, Richard Prayson ², Marcia Leon Rabanal ³, Leonard Calabrese ³ and Rula Hajj-ali ³, ¹Cleveland Clinic Lerner College of Medicine of Case Western Reserve University/Cleveland Clinic, Cleveland, OH, ²Anatomic Pathology/Cleveland Clinic, Cleveland, OH, ³Rheumatologic and Immunologic Disease/Cleveland Clinic, Cleveland, OH
Background/Purpose: Primary central nervous system vasculitis (CNS-V) is vasculitis confined to the brain, spinal cord and meninges. It is a rare condition with unknown pathogenesis.…
Abstract Number: 1721 • 2019 ACR/ARP Annual Meeting
Adult Primary Central Nervous System Vasculitis Treatment and Course: A Long-term Follow-up Study
Carlo Salvarani¹, Robert D Brown ², Teresa JH Christianson ², John Huston III ², Caterina Giannini ² and Gene G Hunder ², ¹Division of Rheumatology, Arcispedale Santa Maria Nuova-IRCCS, Reggio Emilia, Italy, ²Mayo Clinic, Rochester
Background/Purpose: To evaluate long-term treatment and outcomes of a large cohort of patients with primary central nervous system vasculitis (PCNSV)Methods: The study cohort consisted of…
Abstract Number: 2838 • 2018 ACR/ARHP Annual Meeting
Comorbid Vasculitis Among Patients in a National Primary Immunodeficiency Database
Kevin Byram¹, Leonard H. Calabrese² and James Fernandez¹, ¹Cleveland Clinic Foundation, Cleveland, OH, ²Rheumatic & Immunologic Disease and Infectious Disease, Cleveland Clinic Foundation, Cleveland, OH
Background/Purpose: Vasculitis has been reported in patients with various forms of primary immunodeficiency (PID) in case reports in the literature. The goal of this study…
Abstract Number: 2730 • 2017 ACR/ARHP Annual Meeting
Clinical Features and Treatment of Central Nervous System Vasculitis Associated with Acute Posterior Multifocal Placoid Pigment Epitheliopathy
Hiromichi Tamaki¹ and Rula A Hajj-Ali², ¹Department of Rheumatic and Immunologic Diseases, Cleveland Clinic Foundation, Cleveland, OH, ²Rheumatic and Immunologic Disease, Cleveland Clinic, Cleveland, OH
Background/Purpose: Acute posterior Multifocal Placoid Pigment Epitheliopathy (APMPPE) is a rare inflammatory eye disease and some appear to develop central nervous system vasculitis (CNSV). This…
Abstract Number: 2731 • 2017 ACR/ARHP Annual Meeting
The Utility of Unbiased Metagenomic Next Generation Sequencing in the Management of Patients with CNS Vasculitis
Hiromichi Tamaki¹, Michael R Wilson², Leonard H. Calabrese³, Joseph L. DeRisi⁴ and Rula A Hajj-Ali⁵, ¹Department of Rheumatic and Immunologic Diseases, Cleveland Clinic Foundation, Cleveland, OH, ²Department of Neurology, UCSF, San Francisco, CA, ³Rheumatic & Immunologic Disease, Cleveland Clinic Foundation, Cleveland, OH, ⁴Biochemistry and Biophysics, UCSF, San Francisco, CA, ⁵Rheumatology, Cleveland Clinic Foundation, Cleveland, OH
Background/Purpose: In the clinical approach to CNS vasculitis, exclusion of infection is of major concern as some microbes can cause vasculitis, and infections can complicate…
Abstract Number: 2951 • 2016 ACR/ARHP Annual Meeting
Patient Outcomes in Primary Angiitis of the Central Nervous System
Elisabeth Ray¹, Didem Saygin², Anabelle Morales-Mena³, William Messner⁴, Leonard H. Calabrese⁵ and Rula A Hajj-Ali⁶, ¹Rheumatology, Cleveland Clinic, Cleveland, OH, ²Cleveland Clinic, Cleveland, OH, ³Rheumatology, Hillcrest Hospital, Mayfield Heights, OH, ⁴Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, ⁵Rheumatic & Immunologic Disease, Cleveland Clinic, Cleveland, OH, ⁶Rheumatic and Immunologic Dis, Cleveland Clinic, Cleveland, OH
Results: 1855 patient records were identified using the ICD-9 code for cerebral angiitis. 78 patients met inclusion criteria, of which 27 responded to the questionnaires…
Abstract Number: 2952 • 2016 ACR/ARHP Annual Meeting
Differentiation Between Neurosarcoidosis and Primary CNS Vasculitis Based on Clinical and Cerebrospinal Fluid Parameters
Didem Saygin¹, Leonard H. Calabrese², Elisabeth Ray¹, William Messner³, Jinny Tavee⁴ and Rula A Hajj-Ali⁵, ¹Rheumatology, Cleveland Clinic, Cleveland, OH, ²Rheumatic & Immunologic Disease, Cleveland Clinic, Cleveland, OH, ³Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, ⁴Neuromuscular diseases, Cleveland Clinic, Cleveland, OH, ⁵Rheumatic and Immunologic Dis, Cleveland Clinic, Cleveland, OH
Background/Purpose: Neurosarcoidosis is one of the great mimickers of primary angiitis of central nervous system (PACNS) in terms of disease presentation, imaging and pathologic findings.…
Abstract Number: 2953 • 2016 ACR/ARHP Annual Meeting
Comparison of Patient Outcomes in Primary Angiitis of the Central Nervous System and Reversible Cerebral Vasoconstriction Syndrome
Elisabeth Ray¹, Didem Saygin¹, Seby John², William Messner³, Ken Uchino⁴, Leonard H. Calabrese⁵ and Rula A Hajj-Ali⁶, ¹Rheumatology, Cleveland Clinic, Cleveland, OH, ²Cleveland Clinic, Cleveland, OH, ³Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, ⁴Cerebrovascular Center, Cleveland Clinic Foundation, Cleveland, OH, ⁵Rheumatic & Immunologic Disease, Cleveland Clinic, Cleveland, OH, ⁶Rheumatic and Immunologic Dis, Cleveland Clinic, Cleveland, OH
Background/Purpose: Reversible Cerebral Vasoconstriction Syndrome (RCVS) is an important mimic of Primary Angiitis of the Central Nervous System (PACNS). Distinct clinical and diagnostic features differentiate…
Abstract Number: 1993 • 2015 ACR/ARHP Annual Meeting
Imaging Findings of Cerebral Amyloid Angiopathy, Abeta-Related Angiitis (ABRA) and Cerebral Amyloid Angiopathy-Related Inflammation: A Single Institution 25 Year Experience
Carlo Salvarani¹, Jonathan M Morris², Caterina Giannini², Teresa J. H. Christianson³, Robert D. Brown Jr.⁴ and Gene G. Hunder⁵, ¹Rheumatology, Arcispedale S Maria Nuova-IRCCS, Reggio Emilia, Italy, ²Mayo Clinic, Rochester, MN, ³Division of Biomedical Statistics & Informatics, Mayo Clinic, Rochester, MN, ⁴Department of Neurology, Mayo Clinic, Rochester, MN, ⁵Dept Internal Med/Rheum, Mayo Clinic, Rochester, MN
Background/Purpose: To investigate the role of imaging in differentiating cerebral amyloid angiopathy (CAA) with and without inflammation. Methods: We studied 54 patients seen over 25…
Abstract Number: 3179 • 2015 ACR/ARHP Annual Meeting
Diagnosing Childhood Small Vessel CNS Vasculitis
Marinka Twilt¹, Maryam Nabavi Nouri², Pascal N. Tyrrell³, Anastasia Dropol¹, Shehla Sheikh⁴, Cynthia Hawkins⁵ and Susanne Benseler^6,7, ¹Rheumatology, Alberta Children's Hospital, Calgary, AB, Canada, ²Neurology, The Hospital for Sick Childern, Toronto, ON, Canada, ³Department of Medical Imaging, University of Toronto, Toronto, ON, Canada, ⁴Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, ⁵Paediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, ON, Canada, ⁶Alberta Children's Hospital Research Institute/University of Calgary, Calgary, AB, Canada, ⁷Pediatrics/Alberta Children's Hospital, Department of Pediatrics/University of Calgary, Calgary, AB, Canada
Background/Purpose: Childhood primary small vessel CNS vasculitis (SVcPACNS) is an increasingly recognized inflammatory brain disease with high morbidity and mortality mandating an elective brain biopsy…
Abstract Number: 2766 • 2014 ACR/ARHP Annual Meeting
Mycophenolate Mofetil in the Treatment of Primary Central Nervous System Vasculitis
Carlo Salvarani¹, Robert D. Brown Jr.², Teresa J. H. Christianson², John Huston III², Francesco Muratore¹, Caterina Giannini² and Gene G. Hunder³, ¹Rheumatology Unit, Arcispedale S Maria Nuova, Reggio Emilia, Italy, ²Mayo Clinic, Rochester, MN, ³Rheumatology, Mayo Clinic, Rochester, MN
Background/Purpose . The optimal management of primary central nervous system vasculitis (PCNSV) remains unclear. Cyclophosphamyde (CYC) in combination with glucocorticoids (GCs) or GCs alone are…
Abstract Number: 1661 • 2013 ACR/ARHP Annual Meeting
The Spectrum of childhood Inflammatory Brain Diseases; An Increasingly Recognised Field
Marinka Twilt¹, Eyal Muscal², Tania Cellucci³, Pavla Dolezalova⁴, Rob Forsyth⁵, Susan Kim⁶, David A. Cabral⁷, Johannes Roth⁸, Adam Kirton⁹, Rolando Cimaz¹⁰, Jasmin Kummerle-Deschner¹¹, Annet van Royen-Kerkhof¹², Jürgen Brunner¹³, Gaelle Chedeville¹⁴, Jordi Anton¹⁵, Angela Robinson¹⁶, Mary Toth¹⁷, Tilmann Kallinich¹⁸, Claudia Bracaglia¹⁹, Alexis Boneparth²⁰, Shehla Sheikh²¹ and Susanne M. Benseler²¹, ¹Division of Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, ²TCH Pediatric Rheum Center, Baylor College of Medicine, Houston, TX, ³Rheumatology, Hamilton Health Sciences, McMaster, Hamilton, ON, Canada, ⁴Pediatric Rheumatology Unit, Department of Pediatrics and Adolescent Medicine, General University Hospital in Prague, Prague, Czech Republic, ⁵Newcastle upon Tyne's NHS foundation Trust, Newcastle upon Tyne, United Kingdom, ⁶Division of Immunology, Boston Children's Hospital, Boston, MA, ⁷University of British Columbia, Vancouver, BC, Canada, ⁸University of Ottawa, Ottawa, ON, Canada, ⁹Neurology, Alberta Children's Hospital, Calgary, AB, Canada, ¹⁰Rheumatology Unit, A. Meyer Children's Hospital, Florence, Italy, ¹¹University Childrens Clinic Tuebingen, Tuebingen, Germany, ¹²Department of Pediatric Immunology & Rheumatology, Wilhelmina Children’s Hospital, University Medical Center Utrecht, Utrecht, Netherlands, ¹³pediatric Rheumatology, University Children's Hospital, Innsbruck, Austria, ¹⁴Pediatric Rheumatology, Montreal Children's Hospital, Montreal, QC, Canada, ¹⁵Rheumatology, Hospital Sant Joan de Deu, Barcelona, Spain, ¹⁶Pediatrics, Rainbow Babies & Children's Hospital / Case Medical Center, Cleveland, OH, ¹⁷Rheumatology, Akron Children's Hospital, Akron, OH, ¹⁸Charite, University Medicine Berlin, Berlin, Germany, ¹⁹Department of Pediatric Medicine, Division of Rheumatology, Ospedale Pediatrico Bambino Gesù, IRCCS, Rome, Italy, ²⁰Pediatrics, The Children's Hospital at Montefiore, Bronx, NY, ²¹Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada
Background/Purpose: Childhood Inflammatory Brain diseases are potentially life-threatening diseases leading to severe neurological deficits if not treated. The spectrum of childhood inflammatory brain diseases is…
Abstract Number: 741 • 2013 ACR/ARHP Annual Meeting
Granulomatosis With Polyangiitis Central Nervous System Involvement: Presentation and Management
Gonzalo De Luna^1,2, Benjamin Terrier³, Pierre Kaminsky⁴, Francois Maurier⁵, Roser Solans⁶, Raphaèle Seror⁷, Xavier Puéchal⁸, Luc Mouthon⁹ and Loic Guillevin¹⁰, ¹Medecine Interne, Cochin University Hospital, Paris, France, ²Internal Medicine, Hospital Ramon y Cajal, Madrid, Spain, ³Internal Medicine, Cochin University Hospital, Paris, France, ⁴Université de Lorraine, Nancy, F-54000, France; CHU de Nancy, Orphan disease unit, Nancy, F-54000, France;, Nancy, France, ⁵HP Metz Belle Isle Hospital, Department of Internal Medicine, Metz, France, ⁶Autoimmune Systemic Diseases Unit, Department of Internal Medicine, Hospital Vall d'Hebron, Autonomous University of Barcelona, Barcelona, Spain, ⁷Rheumatology, Bicetre university hospital, LE Kremlin-Bicetre, France, ⁸National Referral Center for Rare Systemic Auto-immune Diseases, Hôpital Cochin, AP-HP, Université Paris Descartes, Sorbonne Paris Cité, Paris, France, ⁹Department of Internal Medicine, Referral Center for Rare Autoimmune and Systemic Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, France, Paris, France, ¹⁰Department of Internal Medicine, Referral Center for Rare Autoimmune and Systemic Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, France
Background/Purpose: Granulomatosis with polyangiitis (GPA), a small-sized–vessel vasculitis, commonly involves ear, nose & throat (ENT), lungs and kidneys, and, more rarely, the central nervous system…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].